RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
SCI Pharmtech Stock

SCI Pharmtech ROE 2024

SCI Pharmtech ROE

0.06

Ticker

4119.TW

ISIN

TW0004119003

In 2024, SCI Pharmtech's return on equity (ROE) was 0.06, a -32.08% increase from the 0.09 ROE in the previous year.

SCI Pharmtech Aktienanalyse

What does SCI Pharmtech do?

SCI Pharmtech Inc is a leading company in the pharmaceutical industry based in Zhejiang, China. The company was founded in 2003 and has since grown continuously. Today, the company employs over 100 employees and has become a key player in the global supply chain of pharmaceutical raw materials and intermediates. SCI Pharmtech Inc's business model is based on the development and production of high-quality pharmaceutical intermediates and active pharmaceutical ingredients, as well as the manufacturing of custom chemicals. The company specializes in the production and distribution process, offering its customers a comprehensive range of products that meet the highest quality and safety standards. SCI Pharmtech Inc is divided into various divisions, each specializing in specific product categories. The main divisions are API (Active Pharmaceutical Ingredients), intermediates, and custom synthesis. The API division produces active pharmaceutical ingredients for the pharmaceutical industry, which serve as the basis for drug manufacturing. The intermediates division offers pharmaceutical intermediates used in the synthesis of active pharmaceutical ingredients. The custom synthesis division provides tailored synthesis processes for customers in need of specific chemicals or intermediates. SCI Pharmtech Inc's product portfolio includes Acetamidomalonate, Carbamazepine, and Codergocrine Mesylate, among others. The company also offers custom synthesis services, involving complex chemical syntheses and innovative technologies. SCI Pharmtech Inc places great emphasis on quality and safety. The company operates according to international standards, including GMP (Good Manufacturing Practice), ISO (International Standards Organization), and CE (Conformité Européenne). SCI Pharmtech Inc's products undergo stringent quality controls to ensure compliance with the strict regulations of global pharmaceutical regulatory authorities. Another important concern of SCI Pharmtech Inc is sustainability. The company has developed a sustainable business strategy aimed at minimizing its environmental impact and conserving resources. This includes implementing efficient production processes, reducing energy consumption and CO2 emissions, as well as promoting environmental awareness among employees and customers. Overall, SCI Pharmtech Inc is a dynamic and innovative company specializing in the production of pharmaceutical intermediates and active pharmaceutical ingredients. The company takes pride in offering high-quality products that meet the highest quality and safety standards. Through its sustainable business strategy and adherence to international standards, SCI Pharmtech Inc has achieved an excellent reputation in the pharmaceutical industry and strengthened its presence in the global market. SCI Pharmtech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding SCI Pharmtech's Return on Equity (ROE)

SCI Pharmtech's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing SCI Pharmtech's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

SCI Pharmtech's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in SCI Pharmtech’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about SCI Pharmtech stock

What is the ROE (Return on Equity) of SCI Pharmtech this year?

The ROE of SCI Pharmtech this year is 0.06 undefined.

How has the Return on Equity (ROE) of SCI Pharmtech developed compared to the previous year?

The ROE of SCI Pharmtech has increased by -32.08% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of SCI Pharmtech?

A high ROE indicates that SCI Pharmtech generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of SCI Pharmtech?

A low ROE can indicate that SCI Pharmtech is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of SCI Pharmtech affect the company?

A change in ROE (Return on Equity) of SCI Pharmtech can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of SCI Pharmtech?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of SCI Pharmtech?

Some factors that can influence SCI Pharmtech's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does SCI Pharmtech pay?

Over the past 12 months, SCI Pharmtech paid a dividend of 0.22 TWD . This corresponds to a dividend yield of about 0.24 %. For the coming 12 months, SCI Pharmtech is expected to pay a dividend of 0.22 TWD.

What is the dividend yield of SCI Pharmtech?

The current dividend yield of SCI Pharmtech is 0.24 %.

When does SCI Pharmtech pay dividends?

SCI Pharmtech pays a quarterly dividend. This is distributed in the months of August, September, August, August.

How secure is the dividend of SCI Pharmtech?

SCI Pharmtech paid dividends every year for the past 1 years.

What is the dividend of SCI Pharmtech?

For the upcoming 12 months, dividends amounting to 0.22 TWD are expected. This corresponds to a dividend yield of 0.24 %.

In which sector is SCI Pharmtech located?

SCI Pharmtech is assigned to the 'Health' sector.

Wann musste ich die Aktien von SCI Pharmtech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of SCI Pharmtech from 8/5/2024 amounting to 1.25 TWD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did SCI Pharmtech pay the last dividend?

The last dividend was paid out on 8/5/2024.

What was the dividend of SCI Pharmtech in the year 2023?

In the year 2023, SCI Pharmtech distributed 0.417 TWD as dividends.

In which currency does SCI Pharmtech pay out the dividend?

The dividends of SCI Pharmtech are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von SCI Pharmtech

Our stock analysis for SCI Pharmtech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SCI Pharmtech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.